SummaryA June 2014 Avalere survey asserts that while 90% of pharmaceutical and biotech manufacturers are offering cost-sharing assistance to exchange patients, the type of support, generosity and program structure vary widely.
Matt Brow serves as the president and general manager of Inovalon’s Pharmacy, Life Sciences and Advisory business.
Tune into our third episode of the Avalere Health Essential Voice: Election 2020 series. In this seg...
The Coronavirus Aid, Relief, and Economic Security (CARES) Act appropriated $100 billion for the Pub...